8.61MUSD
0.81
Type
Common Stock
Exchange
OTCQB
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
June
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
5.44
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
-1.045
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
1,300,512
Gross Profit TTM
435,094
EBITDA
-9,393,075
Profit Margin
0.00%
Return On Assets TTM
-14.44%
Return On Equity TTM
-25.71%
Revenue Per Share TTM
0.191
Qtly Revenue Growth YOY
704.10%
Diluted Eps TTM
-1.045
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
6.6197
Price Book MRQ
0.3249
Enterprise Value Revenue
5
Enterprise Value EBITDA
0
90.54
1.12%49.91
0.54%612.14
0.11%90.00
0.00%182.50
0.00%4.40
0.00%19.06
-0.42%43.88
-0.18%74.14
-0.04%444.93
-0.03%